333 related articles for article (PubMed ID: 18154280)
1. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
5. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
6. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
Ko S; Lee W; Lee S; Park H
J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
[TBL] [Abstract][Full Text] [Related]
7. What's new on CDC25 phosphatase inhibitors.
Contour-Galcera MO; Sidhu A; Prévost G; Bigg D; Ducommun B
Pharmacol Ther; 2007 Jul; 115(1):1-12. PubMed ID: 17531323
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
[TBL] [Abstract][Full Text] [Related]
9. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
10. Cdc25 phosphatases: structure, specificity, and mechanism.
Rudolph J
Biochemistry; 2007 Mar; 46(12):3595-604. PubMed ID: 17328562
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the CDC25 phosphatases.
Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
[TBL] [Abstract][Full Text] [Related]
13. Flexibility and inhibitor binding in cdc25 phosphatases.
Arantes GM
Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
[TBL] [Abstract][Full Text] [Related]
14. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
Park H; Bahn YJ; Ryu SE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
[TBL] [Abstract][Full Text] [Related]
15. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
[No Abstract] [Full Text] [Related]
16. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
[TBL] [Abstract][Full Text] [Related]
17. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
Wang JG; Xiao YJ; Li YH; Ma Y; Li ZM
Bioorg Med Chem; 2007 Jan; 15(1):374-80. PubMed ID: 17049866
[TBL] [Abstract][Full Text] [Related]
18. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
[TBL] [Abstract][Full Text] [Related]
19. Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure.
Park H; Jeon YH
J Mol Model; 2008 Sep; 14(9):833-41. PubMed ID: 18504625
[TBL] [Abstract][Full Text] [Related]
20. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
